Multiple Myeloma Research Papers

  • January 31, 2018

    The MMRF's early investment in Selinexor yields promising results for myeloma patients
    Learn More

  • January 1, 2018

    The MMRF hosts educational Patient Summits around the country, bringing patients and caregivers together with top experts. View Upcoming Summits

  • December 18, 2017

    Founder Kathy Giusti explains how the Harvard Business School Kraft Accelerator program is working across all cancers to speed precision cures
    Learn More

  • December 15, 2017

    "Meeting Highlights for Patients: ASH 2017" Learn about the latest data presented at ASH.
    View Slides

  • November 9, 2017

    Learn how direct-to-consumer marketing strategies can be used to reach patients throughout their cancer journey, co-authored by Kathy Giusti
    Learn More

  • September 11, 2017

    MMRF Founder Kathy Giusti named 1 of 100 Visionaries of our time by the Einstein Foundation
    Learn More

  • September 8, 2017

    Tom Brokaw gives inspiring speech at MMRF Leadership Circle Summit on how his life was changed, for the better, by his diagnosis
    Watch Now

  • August 14, 2017

    MMRF Founder Kathy Giusti tells Rebecca Jarvis how the MMRF shares knowledge, collaborates, and builds clinical networks on the No Limits podcast
    Listen Now

  • August 10, 2017

    Kathy Giusti addresses Precision Medicine 2017: Breakaway Business Models at Harvard Medical School highlighting the importance of data sharing in cancer treatment
    Learn More

  • August 1, 2017

    MMRF SVP of Research, Daniel Auclair, is chosen as a member of the 2017 PharmaVOICE 100!
    Learn More

  • June 29, 2017

    MMRF launches the Answer Fund, a 3 year, $5M investment in answering the most pressing questions in MM 
    Learn More

  • June 29, 2017

    MMRF announces a 3 year, $15M initiative to bring personalized, innovative immunotherapies to myeloma 
    Learn More

  • June 29, 2017

    Announcing the first ever research program solely dedicated to the early detection and prevention of Multiple Myeloma
    Learn More

  • June 21, 2017

    HBS Kraft Accelerator co-chairs Kathy Giusti & Richard Hamermesh discuss leveraging Collective Impact to advance Precision Medicine
    Read More

  • June 19, 2017

    Watch this informative panel on the value of data sharing at Precision Medicine World Conference feat. Kathy Giusti, Bill Dalton (M2Gen), Robert Califf, and Rick Klausner Watch Now

  • May 15, 2017

    Kathy Giusti explains the vital role that the MMRF plays in optimizing a patient's journey and decision-making
    Read More

  • April 18, 2017

    MMRF Founder Kathy Giusti discusses how innovative systems like the MMRF precision medicine model are overcoming challenges in data-sharing in an interview with PMWC
    Read More

  • February 23, 2017

    Knowing as much as you can about your cancer can be scary, but Kathy Giusti explains that this information can be vital to bring patients the right, specific precision treatments
    Read More

  • September 28, 2016

    Former Time Warner CEO & MM patient shares importance of patients being active participants in clinical research Read More

  • September 13, 2016

    MMRF and Memorial Sloan Kettering to launch a new clinical trial to identify potential genomic markers linked to achieving and maintaining deep response to therapy Read More

  • August 1, 2016

    MMRF Founder honored by PharmaVOICE magazine for continued innovation and improving patient outcomes Read More

  • June 3, 2016

    MMRF Founder Kathy Giusti to Co-Chair Harvard Business School/Kraft Precision Medicine Accelerator Read More

  • May 24, 2016

    Leaders Applaud MMRF Precision Medicine Model at the Milken Institute Global Conference Watch Now

  • May 6, 2016

    Kathy Giusti sits down with Dr. Nancy Snyderman at the 2016 World Medical Innovation Forum
    Watch Now

  • April 27, 2016

    "These 3 Former Business Leaders Are Disrupting Medicine" Read more

  • April 6, 2016

    "Kathy Giusti: The Cancer Patient Who Became an Advocate for Precision Medicine" Read more

  • March 1, 2016

    Learn more about Kathy Giusti and the MMRF at the 2016 Precision Medicine World Conference Learn more

  • February 13, 2016

    Read how MMRF Founder Kathy Giusti took a business approach to cancer advocacy Read More

  • January 4, 2016

    The MMRF and "New Weapons in the Fight Against Multiple Myeloma". Read More

  • August 6, 2015

    Connect with patients, engage with experts, get the information you need! MMRF CoMMunity Gateway

  • 1. Gozzetti A, Candi V, Papini G et al. Therapeutic advancements in multiple myeloma. Front Oncol 2014;4:241 doi:10.3389/fonc.2014.00241[PMC free article][PubMed]

    2. Kumar SK, Dispenzieri A, Lacy MQ et al. Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients. Leukemia 2014;28:1122–8. doi:10.1038/leu.2013.313[PMC free article][PubMed]

    3. Blade J, Rosinol L. Complications of multiple myeloma. Hematol Oncol Clin North Am 2007;21:1231–46, xi. doi:10.1016/j.hoc.2007.08.006[PubMed]

    4. Rajkumar SV. MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Hematology Am Soc Hematol Educ Program 2005:340.–. doi:10.1182/asheducation-2005.1.340[PubMed]

    5. Monninkhof EM, Elias SG, Vlems FA et al. Physical activity and breast cancer: a systematic review. Epidemiology 2007;18:137–57. doi:10.1097/01.ede.0000251167.75581.98[PubMed]

    6. Tardon A, Lee WJ, Delgado-Rodriguez M et al. Leisure-time physical activity and lung cancer: a meta-analysis. Cancer Causes Control 2005;16:389–97. doi:10.1007/s10552-004-5026-9[PMC free article][PubMed]

    7. Lee IM. Physical activity and cancer prevention—data from epidemiologic studies. Med Sci Sports Exerc 2003;35:1823–7. doi:10.1249/01.MSS.0000093620.27893.23[PubMed]

    8. Jochem C, Leitzmann MF, Keimling M et al. Physical activity in relation to risk of hematologic cancers: a systematic review and meta-analysis. Cancer Epidem Biomar 2014;23:833–46. doi:10.1158/1055-9965.EPI-13-0699[PubMed]

    9. Doyle C, Kushi LH, Byers T, et al. , 2006 Nutrition, Physical Activity and Cancer Survivorship Advisory Committee; American Cancer Society. Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2006;56:323–53. doi:10.3322/canjclin.56.6.323[PubMed]

    10. Speck RM, Courneya KS, Masse LC et al. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010;4:87–100. doi:10.1007/s11764-009-0110-5[PubMed]

    11. Friedenreich CM. Physical activity and breast cancer: review of the epidemiologic evidence and biologic mechanisms. Recent Results Cancer Res 2011;188:125–39. doi:10.1007/978-3-642-10858-7_11[PubMed]

    12. Sun JY, Shi L, Gao XD et al. Physical activity and risk of lung cancer: a meta-analysis of prospective cohort studies. Asian Pac J Cancer Prev 2012;13:3143–7. doi:10.7314/APJCP.2012.13.7.3143[PubMed]

    13. Thorsen L, Courneya KS, Stevinson C et al. A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer 2008;16:987–97. doi:10.1007/s00520-008-0411-7[PubMed]

    14. Davis K, Drey N, Gould D. What are scoping studies? A review of the nursing literature. Int J Nurs Stud 2009;46:1386–400. doi:10.1016/j.ijnurstu.2009.02.010[PubMed]

    15. Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010;5:69 doi:10.1186/1748-5908-5-69[PMC free article][PubMed]

    16. Hofmann JN, Moore SC, Lim U et al. Body mass index and physical activity at different ages and risk of multiple myeloma in the NIH-AARP Diet and Health Study. Am J Epidemiol 2013;177:776–86. doi:10.1093/aje/kws295[PMC free article][PubMed]

    17. Khan MM, Mori M, Sakauchi F et al. Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study. Asian Pac J Cancer Prev 2006;7:575–81. [PubMed]

    18. Birmann BM, Giovannucci E, Rosner B et al. Body mass index, physical activity, and risk of multiple myeloma. Cancer Epidem Biomar 2007;16:1474–8. doi:10.1158/1055-9965.EPI-07-0143[PMC free article][PubMed]

    19. Coon SK, Coleman EA. Exercise decisions within the context of multiple myeloma, transplant, and fatigue. Cancer Nurs 2004;27:108–18. doi:10.1097/00002820-200403000-00003[PubMed]

    20. Coon SK, Coleman EA. Keep moving: patients with myeloma talk about exercise and fatigue. Oncol Nurs Forum 2004;31:1127–35. doi:10.1188/04.ONF.1127-1135[PubMed]

    21. Craike MJ, Hose K, Courneya KS et al. Perceived benefits and barriers to exercise for recently treated patients with multiple myeloma: a qualitative study. BMC Cancer 2013;13:319 doi:10.1186/1471-2407-13-319[PMC free article][PubMed]

    22. Coleman EA, Coon SK, Kennedy RL et al. Effects of exercise in combination with epoetin alfa during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for multiple myeloma. Oncol Nurs Forum 2008;35:E53–61. doi:10.1188/08.ONF.E53-E61[PMC free article][PubMed]

    23. Coleman EA, Goodwin JA, Kennedy R et al. Effects of exercise on fatigue, sleep, and performance: a randomized trial. Oncol Nurs Forum 2012;39:468–77. doi:10.1188/12.ONF.468-477[PubMed]

    24. Coleman EA, Coon S, Hall-Barrow J et al. Feasibility of exercise duration treatment for multiple myeloma. Cancer Nurs 2003;26:410–19. doi:10.1097/00002820-200310000-00012[PubMed]

    25. Groeneveldt L, Mein G, Garrod R et al. A mixed exercise training programme is feasible and safe and may improve quality of life and muscle strength in multiple myeloma survivors. BMC Cancer 2013;13:31 doi:10.1186/1471-2407-13-31[PMC free article][PubMed]

    26. Craike M, Hose K, Livingston PM. Physical activity participation and barriers for people with multiple myeloma. Support Care Cancer 2013;21:927–34. doi:10.1007/s00520-012-1607-4[PubMed]

    27. Jones L, Courneya K, Vallance J et al. Association between exercise and quality of life in multiple myeloma cancer survivors. Support Cancer Care 2004;12:780–8. doi:10.1007/s00520-004-0668-4[PubMed]

    28. Boullosa DA, Leicht AS, Tuimil JL. Impact of fire-fighters training on a female with smoldering multiple myeloma. J Sport Med Phys Fit 2010;50:326–9. [PubMed]

    29. Boullosa DA, Abreu L, Tonello L et al. Exercise is medicine: case report of a woman with smoldering multiple myeloma. Med Sci Sports Exerc 2013;45:1223–8. doi:10.1249/MSS.0b013e3182880359[PubMed]

    30. Persoon S, Kersten MJ, Chinapaw MJ et al. Design of the EXercise Intervention after Stem cell Transplantation (EXIST) study: a randomized controlled trial to evaluate the effectiveness and cost-effectiveness of an individualized high intensity physical exercise program on fitness and fatigue in patients with multiple myeloma or (non-) Hodgkin's lymphoma treated with high dose chemotherapy and autologous stem cell transplantation. BMC Cancer 2010;10:671 doi:10.1186/1471-2407-10-671[PMC free article][PubMed]

    31. Dimeo F, Tilmann M, Bertz H et al. Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation. Cancer 1997;79:1717–22. doi:10.1002/(SICI)1097-0142(19970501)79:9<1717::AID-CNCR12>3.0.CO;2-0[PubMed]

    32. Hayes S, Davies P, Parker T et al. Quality of life changes following peripheral blood stem cell transplantation and participation in a mixed-type, moderate intensity, exercise program. Bone Marrow Transplant 2004;33:553–8. doi:10.1038/sj.bmt.1704378[PubMed]

    Comments

    Leave a Reply

    Your email address will not be published. Required fields are marked *